BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
June 18, 2013
View Archived Issues
New biomarkers for celiac disease reported
Read More
Researchers prepare and test labeled iRGD peptides as cancer diagnostics
Read More
Phase I evaluation of oligonucleotide therapy in patients with ALS
Read More
Dainippon Sumitomo Pharma presents novel selective 11-beta-HSD1 inhibitor
Read More
New CCR1 and CCR6 receptor inhibitors for the treatment of rheumatoid arthritis described
Read More
Results presented from head-to-head phase II study of pateclizumab versus adalimumab
Read More
Roche presents final stage 1 results from obinutuzumab study
Read More
Portola Pharmaceuticals patents novel tyrosine-protein kinase inhibitors
Read More
Merck KGaA discloses new protein kinase inhibitors
Read More
Johnson & Johnson to acquire Aragon Pharmaceuticals
Read More
Inovio Pharmaceuticals reports data from preclinical trial of its H7N9 DNA vaccine
Read More
Oxygen Healthcare Research divulges novel histamine H3 receptor ligands
Read More
Ambrx and Zhejiang Medicine collaborate on ARX-788 for breast cancer
Read More
Shionogi to collaborate with Irish universities
Read More
Athera Biotechnologies obtains E.U. grants for its antibody therapy
Read More
EryDex obtains orphan drug designation for ataxia telangiectasia in Europe
Read More
Aeroquin shows sustained therapeutic efficacy in phase III trial for cystic fibrosis
Read More
MannKind completes phase III study of Afrezza in type 2 diabetes
Read More
Eli Lilly exercises rights to Transition Therapeutics' TT-401
Read More
Nitto Denko's lidocaine patch receives additional indication approval in Japan
Read More
Abilify granted additional indication approval as adjunctive therapy for depression
Read More
Summit achieves milestone in development of C. difficile antibiotic
Read More
Silence Therapeutics advances phase Ib/IIa study of RNAi therapeutic
Read More
FDA accepts Ruconest BLA for review
Read More
Takeda launches Nesina and fixed-dose combinations for type 2 diabetes in the U.S.
Read More
Canadian acceptance of MycoTool for release testing of Roche product
Read More